Australian research has recently examined the issue of “misappropriated” medicines in the Emergency Department. The researchers completed a retrospective audit of medications procured and administered (and equipment replaced) during the year 2016, in a tertiary referral ED. Medication procurement data were obtained from the pharmacy dispensing/distribution system and and administration data were harvested from the electronic prescribing system. The medication ‘discrepancy rate’ was defined as the percentage of a medication procured that could not be accounted for by electronic administrations. Discrepancy rates for paracetamol 500 mg and 665 mg tablets were 23.3% and 54.9%, respectively. An intervention to reduce access to the paracetamol/codeine (500/30 mg per tablet) product produced a spectacular reduction in the discrepancy rate for this product from 70.5% (pre-intervention) to 8.8% (post-intervention). Orally administered medications with the potential for misappropriation had high discrepancy rates: caffeine (90.6%), cephalexin 62.9%), ondansetron (50.1%), pantoprazole (42.9%),amoxycillin (41.1%), metaclopramide (41.0%) and the ‘morning after pill’ (levonorgestrel) (36.4%). Aside from obvious economic considerations, theft of scheduled medicines has medication safety implications, emphasizing the need to regularly review and implement remedial actions as needed. The original paper can be viewed here.
Recent Posts
Archives
- October 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018